The IPSS-M is the newest MDS prognosis calculator that combines genomic profiling with hematologic and cytogenetic parameters, improving the risk stratification of patients with MDS. This is a valuable tool for clinical decision-making, offering the prospect of tailoring diagnosis and therapeutic interventions to each patient’s molecular profile.

Who is the MDS Foundation? We are a global non-profit advocacy organization building critical awareness of Myelodysplastic Syndromes (MDS) - a rare, often undetected blood cancer. The MDS Foundation has supported patients and their families as well as healthcare providers in the fields of MDS, AML and other related cancers for over 30 years.

2023年12月13日 · 2023 MDS Symposium MDS Regional Symposium MDS Centers of Excellence Professional Learning Center You and MDS VJHemOnc Webinars Menu 2 Material Order Form touchONCOLOGY and touchHAEMATOLOGY IPSS-R Calculator View Events Young Investigator Grants MDS Professional Working Groups

Myelodysplastic Syndromes (MDS) are a group of diverse bone marrow disorders in which the bone marrow does not produce enough healthy blood cells. MDS is often referred to as a "bone marrow failure disorder". MDS is primarily a disease of the elderly (most patients are older than age 65), but MDS can affect younger patients as well.

We will provide information related to myelodysplastic syndrome (MDS), introduce patient Mr./Ms. to the International MDS Foundation-accredited Center of Excellence, support physicians, nurses, pharmacists and patient Mr./Ms., share new research and …

The MDS Foundation, Inc.'s Young Investigator Grant provides an investigator, early in their career, the opportunity to initiate, continue or complete a project that focuses on either basic or clinical management into the causation, epidemiology, molecular biology, cytogenetics, morphology, prognosis and treatment of the Myelodysplastic Syndromes.

Who is the MDS Foundation? We are a global non-profit advocacy organization building critical awareness of Myelodysplastic Syndromes (MDS) - a rare, often undetected blood cancer. The MDS Foundation has supported patients and their families as well as healthcare providers in the fields of MDS, AML and other related cancers for over 30 years.

The MDS Foundation is a global non-profit advocacy organization that for over 30 years has supported patients and their families as well as healthcare providers in the fields of MDS and its related diseases.

2025年2月25日 · MDS Patient & Family Report. This new initiative of the MDS Foundation is devoted to patients, family members, and other non-professional interested people. In each episode, experts in the field will discuss novel information on MDS, such as new diagnostic techniques, new therapies etc.

2024年12月6日 · We are thrilled to invite you to the most anticipated gathering of international MDS experts. Join us for the MDS 2025 Congress in Rotterdam, where you’ll have the opportunity to explore the forefront of Myelodysplastic Syndromes, connect with leading international experts, and gain valuable insights into the latest advances, discoveries, basic and translational research, as well as MDS ...